AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2014

May 22, 2014

30870_dirs_2014-05-22_4db370dc-6cd1-4a9e-b16a-b04a5951e0bf.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2014-05-21

Reporting Person: GAGE L PATRICK (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2014-05-21	Non-Qualified Stock Option (right to buy)	$4.44	A	10000	Acquired	2024-05-21	Common Stock (10000)	Direct

Footnotes

F1: This option shall vest and become exercisable as to 10,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2015.